Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Elosulfase alfa (D10333) | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
(D10333) 💬 | [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
| 2 | Elosulfase Alfa 1 MG/ML Intravenous Solution [VIMIZIM] (D10333) | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
(D10333) 💬 | [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
| 3 | Vimizim® (elosulfase alfa) (D10333) | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
(D10333) 💬 | [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |